Skip to main content
SpringerLink
Log in

Colloid solutions: a clinical update

  • Review Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Albumin, dextran, gelatin, and hydroxyethyl starch (HES) solutions are colloids that efficiently expand the circulating blood volume. The administration of colloids restores the intravascular volume with minimal risk of tissue edema in comparison with crystalloid solutions alone. However, colloids are always given for surgical and critically ill patients. The type of the colloid, volumes applied, aggressiveness of fluid resuscitation, and the volume status at the initial phase of administration determine their clinical responses. The outcome after fluid resuscitation with various colloids in critically ill patients seems to be comparable according to systematic reviews. A randomized, adequately powered clinical trial comparing modern nonprotein colloid to albumin is still lacking. Rapidly degradable HES solutions have good hemodynamic effects, and the risk of adverse renal and coagulation effects, as well as allergic reactions, is minimal. The current investigation has also shown the beneficial effect of HES solution (especially HES 130/0.4) on inflammatory response, postoperative nausea and vomiting, and postoperative outcome. The indication of colloids with an assessment of the degree of hypovolemia and safety profiles should thus be taken into consideration before colloid administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2008. doi:10.1002/14651858.CD001319.pub.2.

  2. Perner A, Åneman A, Guttormsen AB, Kárason S, Tenhunen J. Preferences for colloid use in Scandinavian intensive care units. Acta Anaesthesiol Scand. 2008;52:750–8.

    Article  Google Scholar 

  3. Chappell D, Jacob M, Hofmann-Kiefer K, Conzen P, Rehm M. A rational approach to perioperative fluid management. Anesthesiology. 2008;109:723–40.

    Article  PubMed  Google Scholar 

  4. Grocott MP, Mythen MG, Gan TJ. Perioperative fluid management and clinical outcomes in adults. Anesth Analg. 2005;100:1093–106.

    Article  PubMed  Google Scholar 

  5. Perel P, Roberts I, Pearson M. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2007. doi:10.1002/14651858.CD000567.pub3.

  6. Hiippala S, Linko K, Myllylä G, Lalla M, Hekali R, Makelainen A. Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiol Scand. 1995;39:228–35.

    Article  CAS  PubMed  Google Scholar 

  7. Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258–66.

    Article  PubMed  Google Scholar 

  8. Barron ME, Wilkes M, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg. 2004;139:552–63.

    Article  CAS  PubMed  Google Scholar 

  9. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence risk factors mechanisms. A French multicenter prospective study. Ann Fr Anest Reanim. 1994;13:301–10.

    CAS  Google Scholar 

  10. Kohler H, Zschiedrich H, Clasen R, Linfante A, Gamm H. The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure, and renal function in human volunteers. Anaesthetist. 1982;31:61–7.

    CAS  Google Scholar 

  11. Ljungström KG. Safety of dextran in relation to other colloids—ten years experience with hapten inhibition. Infus Ther Transfus Med. 1993;20:206–10.

    Google Scholar 

  12. Van der Linden P, Ickx BE. The effects of colloid solutions on hemostasis. Can J Anaesth. 2006;53:S30–9.

    Article  PubMed  Google Scholar 

  13. Nearman HS, Herman ML. Toxic effects of colloids in the intensive care unit. Crit Care Clin. 1991;7:713–23.

    CAS  PubMed  Google Scholar 

  14. Kramer GC, Wade CE, Prough DS. Hypertonic saline dextran: efficacy and regulatory approval. Acta Anaesthesiol Scand. 1998;42:141–4.

    Article  CAS  PubMed  Google Scholar 

  15. Peano S, Reiner G, Carbonatto M, Bodenbender L, Boland P, Abel KJ. Determination of the clearance factor for transmissible spongiform encephalopathy agents during the manufacturing process of polygeline. Intensive Care Med. 2000;26:608–12.

    Article  CAS  PubMed  Google Scholar 

  16. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med. 1999;25:258–68.

    Article  CAS  PubMed  Google Scholar 

  17. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet. 2005;44:681–99.

    Article  CAS  PubMed  Google Scholar 

  18. Westphal M, James MFM, Kozek-Langenecker S, Stocker R, Guidet B, van Aken H. Hydroxyethyl starches. Anesthesiology. 2009;111:187–202.

    Article  CAS  PubMed  Google Scholar 

  19. Lehmann GB, Asskali F, Boll M, Burmeister MA, Marx G, Hilgers R, Förster H. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth. 2007;98:635–44.

    Article  CAS  PubMed  Google Scholar 

  20. Shatney CH, Chaudry IH. Hydroxyethyl starch administration does not depress reticuloendothelial function or increase mortality from sepsis. Circ Shock. 1994;13:21–6.

    Google Scholar 

  21. Sharland C, Huggett A, Nielson MS, Friedmann PS. Persistent pruritus after pentastarch infusions in intensive care patients. Anaesthesia. 1999;54:500–1.

    Article  CAS  PubMed  Google Scholar 

  22. Morgan PW, Berridge JC. Giving long-persistent starch as volume replacement can cause pruritus after cardiac surgery. Br J Anaesth. 2000;85:696–9.

    Article  CAS  PubMed  Google Scholar 

  23. Christensen P, Andersson J, Rasmussen SE, Andersen PK, Henneberg SW. Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients. Acta Anaesthesiol Scand. 2001;45:414–20.

    Article  CAS  PubMed  Google Scholar 

  24. Rehm M, Haller M, Orth V, Kreimeier U, Jacob M, Dressel H, Mayer S, Brechtelsbauer H, Finsterer U. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology. 2001;95:849–56.

    Article  CAS  PubMed  Google Scholar 

  25. Jacob M, Rehm M, Orth V, Lotsch M, Brechtelsbauer H, Weninger E, Finsterer U. Exact measurement of the volume effect of 6% hydroxyethyl starch 130/0.4 (Voluven®) during acute preoperative normovolemic hemodilution. Anaesthesist. 2003;52:896–904.

    Article  CAS  PubMed  Google Scholar 

  26. Rehm M, Orth V, Kreimeier U, Thiel M, Haller M, Brechtelsbauer H, Finsterer U. Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy. Anesthesiology. 2000;92:657–64.

    Article  CAS  PubMed  Google Scholar 

  27. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. 1991;266:1242–5.

    Article  CAS  PubMed  Google Scholar 

  28. Venn R, Steele A, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88:65–71.

    Article  CAS  PubMed  Google Scholar 

  29. Varpula M, Karlsson S, Parviainen I, Ruokonen E, Pettilä V, Finnsepsis Study Group. Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand. 2007;51:1320–6.

    Article  CAS  PubMed  Google Scholar 

  30. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–77.

    Article  CAS  PubMed  Google Scholar 

  31. Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med. 2002;30:300–5.

    Article  PubMed  Google Scholar 

  32. Friedman Z, Berkenstadt H, Preisman S, Perel A. A comparison of lactated Ringer’s solution to hydroxyethyl starch 6% in a model of severe hemorrhagic shock and continuous bleeding in dogs. Anesth Analg. 2003;96:39–45.

    Article  CAS  PubMed  Google Scholar 

  33. Boura C, Caron A, Longrois D, Mertes PM, Labrude P, Menu P. Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance. Shock. 2003;19:176–82.

    Article  PubMed  Google Scholar 

  34. Moss GS, Lowe RJ, Jilek J, Levine HD. Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial. Surgery (St. Louis). 1981;89:434–8.

    CAS  Google Scholar 

  35. Nagy KK, Davis J, Duda J, Fildes J, Roberts R, Barrett J. A comparison of pentastarch and lactated Ringer’s solution in the resuscitation of patients with hemorrhagic shock. Circ Shock. 1993;40:289–94.

    CAS  PubMed  Google Scholar 

  36. Younes RN, Yin KC, Amino CJ, Itinoshe M, Rocha e Silva M, Birolini D. Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room. World J Surg. 1998;22:2–5.

    Article  CAS  PubMed  Google Scholar 

  37. Lowe RJ, Moss GS, Jilek J, Levine HD. Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man. Surgery (St. Louis). 1977;81:676–83.

    CAS  Google Scholar 

  38. Modig J. Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome: a randomized study in man after traumatic-haemorrhagic shock. Resuscitation. 1983;10:219–26.

    Article  CAS  PubMed  Google Scholar 

  39. Vincent J-L. The pros and cons of hydroxyethyl starch solutions. Anesth Analg. 2007;104:484–6.

    Article  PubMed  Google Scholar 

  40. Boldt J. Volume replacement in the surgical patient–does the type of solution make a difference? Br J Anaesth. 2000;84:783–93.

    CAS  PubMed  Google Scholar 

  41. Tølløfsrud S, Svennevig JL, Breivik H, Kongsgaard U, Øzer M, Hysing E, Mohr B, Seem E, Geiran O, Abdelnour M, Frøysaker T, Noddeland H. Fluid balance and pulmonary functions during and after coronary artery surgery: Ringer’s acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiol Scand. 1995;39:671–7.

    Article  PubMed  Google Scholar 

  42. Friedman G, Jankowski S, Shahla M, Gomez J, Vincent JL. Hemodynamic effects of 6 and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients. J Clin Anesth. 2008;20:528–33.

    Article  CAS  PubMed  Google Scholar 

  43. Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331:1105–9.

    Article  CAS  PubMed  Google Scholar 

  44. Mythen MG, Webb AR. Preoperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg. 1995;130:423–9.

    CAS  PubMed  Google Scholar 

  45. Krausz MM, Bashenko Y, Hirsh M. Crystalloid and colloid resuscitation of uncontrolled hemorrhagic shock following massive splenic injury. Shock. 2001;16:383–8.

    Article  CAS  PubMed  Google Scholar 

  46. Karanko MS. Effects of three colloid solutions on plasma volume and hemodynamics after coronary bypass surgery. Crit Care Med. 1987;15:1015–22.

    Article  CAS  PubMed  Google Scholar 

  47. Gallandat Huet RC, Siemons AW, Baus D, van Rooyen-Butijn WT, Haagenaars JA, van Oeveren W, Bepperling F. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth. 2000;47:1207–15.

    Article  CAS  PubMed  Google Scholar 

  48. Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2001;15:316–21.

    Article  CAS  PubMed  Google Scholar 

  49. Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg. 2001;92:565–71.

    Article  CAS  PubMed  Google Scholar 

  50. Van der Linden P, De Hert S, Daper A, Trenchant A, Schmartz D, Defrance P, Kimbimbi P. 3.5% Urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth. 2004;51:236–41.

    Article  PubMed  Google Scholar 

  51. Van der Linden P, De Hert S, Deraedt D, Deraedt D, Cronheecke S, De Decker K, De Paep R, Rodrigus I, Daper A, Trenchant A. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg. 2005;101:629–34.

    Article  PubMed  Google Scholar 

  52. Mortelmans YJ, Vermaut G, Verbruggen AM, Arnout JF, Vermylen J, Van Aken H, Mortelmans LA. Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution. Anesth Analg. 1995;81:1235–42.

    Article  CAS  PubMed  Google Scholar 

  53. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911–6.

    Article  CAS  PubMed  Google Scholar 

  54. Molnar Z, Mikor A, Leiner T, Szakmany T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med. 2004;30:1356–60.

    Article  PubMed  Google Scholar 

  55. Boldt J, Heesen M, Müller M, Papsdorf M, Hempelmann G. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg. 1996;83:254–61.

    Article  CAS  PubMed  Google Scholar 

  56. Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: is there a difference? Intensive Care Med. 1998;24:28–36.

    Article  CAS  PubMed  Google Scholar 

  57. Palumbo D, Servillo G, D’Amato L, Volpe ML, Capogrosso G, De Robertis E, Piazza O, Tufano R. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol. 2006;72:655–64.

    CAS  PubMed  Google Scholar 

  58. Kuitunen A, Suojaranta-Ylinen R, Kukkonen S, Niemi T. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5), and 4% human albumin after cardiac surgery. Scand J Surg. 2007;96:72–8.

    CAS  PubMed  Google Scholar 

  59. Niemi T, Schramko A, Kuitunen A, Kukkonen S, Suojaranta-Ylinen R. Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin. Scand J Surg. 2008;97:259–65.

    CAS  PubMed  Google Scholar 

  60. Moretti EW, Robertson KM, El-Moalem H, Gan TJ. Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration. Anesth Analg. 2003;96:611–7.

    Article  PubMed  Google Scholar 

  61. Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions. Crit Care Med. 1982;10:159–62.

    Article  CAS  PubMed  Google Scholar 

  62. Prien T, Backhaus N, Pelster F, Pircher W, Bunte H, Lawin P. Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery. J Clin Anesth. 1990;2:317–23.

    Article  CAS  PubMed  Google Scholar 

  63. Rizoli SB. Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma. 2003;54:S82–8.

    PubMed  Google Scholar 

  64. Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med. 1990;18:728–33.

    Article  CAS  PubMed  Google Scholar 

  65. Schertel ER, Allen DA, Muir WW, Hansen BD. Evaluation of a hypertonic sodium chloride/dextran solution for treatment of traumatic shock in dogs. J Am Vet Med Assoc. 1996;208:366–70.

    CAS  PubMed  Google Scholar 

  66. Marx G, Cobas MM, Schuerholz T, Vangerow B, Gratz KF, Hecker H, Sumpelmann R, Rueckoldt H, Leuwer M. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med. 2002;28:629–35.

    Article  CAS  PubMed  Google Scholar 

  67. Zhang H, Voglis S, Kim CH, Slutsky AS. Effects of albumin and Ringer’s lactate on production of lung cytokines and hydrogen peroxide after resuscitated hemorrhage and endotoxemia in rats. Crit Care Med. 2003;31:1515–22.

    Article  CAS  PubMed  Google Scholar 

  68. Menger MD, Sack FU, Hammersen F, Messmer K. Tissue oxygenation after prolonged ischemia in skeletal muscle: therapeutic effect of prophylactic isovolemic hemodilution. Adv Exp Med Biol. 1989;248:387–95.

    CAS  PubMed  Google Scholar 

  69. Webb AR, Moss RF, Tighe D, Mythen MG, al-Saady N, Joseph AE, Bennett ED. A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis. Intensive Care Med. 1992;18:348–55.

    Article  CAS  PubMed  Google Scholar 

  70. Feng X, Yan W, Wang Z, Liu J, Yu M, Zhu S, Xu J. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg. 2007;104:624–30.

    Article  CAS  PubMed  Google Scholar 

  71. Boldt J, Zickmann B, Rapin J, Hammermann H, Dapper F, Hempelmann G. Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiol Scand. 1994;38:432–8.

    Article  CAS  PubMed  Google Scholar 

  72. Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg. 2005;100:1773–80.

    Article  CAS  PubMed  Google Scholar 

  73. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg. 2001;93:405–9.

    Article  CAS  PubMed  Google Scholar 

  74. Lang K, Suttner S, Boldt J, Kumle B, Nagel D. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anaesth. 2003;50:1009–16.

    Article  PubMed  Google Scholar 

  75. Martin G, Bennett-Guerrero E, Wakeling H, Kumle B, Nagel D. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer’s solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth. 2002;16:441–6.

    Article  CAS  PubMed  Google Scholar 

  76. Boldt J, Schöllhorn T, Münchbach J, Pabsdorf M. A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. Eur J Anaesthesiol. 2007;24:267–75.

    Article  CAS  PubMed  Google Scholar 

  77. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A. The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients. Intensive Care Med. 2009;35:462–70.

    Article  PubMed  Google Scholar 

  78. Schierhout G, Roberts I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ. 1999;316:961–4.

    Google Scholar 

  79. Choi PTL, Yip G, Quinonez LG, Cook DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med. 1999;27:200–10.

    Article  CAS  PubMed  Google Scholar 

  80. Roberts I, Alderson P, Bunn F, Chinnock P, Ker K, Schierhout G. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2004. doi:10.1002/14651858.CD000567.pub3.

  81. Stockwell MA, Scott A, Day A, Riley B, Soni N. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia. 1992;47:7–9.

    Article  CAS  PubMed  Google Scholar 

  82. Boldt J, Brosch C, Ducke M, Papsdorf M, Lehmann A. Influence of volume therapy with a modern hydroxyethyl starch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Crit Care Med. 2007;35:2740–6.

    Article  CAS  PubMed  Google Scholar 

  83. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319–34.

    Article  PubMed  Google Scholar 

  84. Boldt J, Brosch C, Röhm K, Lehmann A, Mengistu A, Suttner S. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg. 2008;107:1496–503.

    Article  CAS  PubMed  Google Scholar 

  85. Holm C. Resuscitation in shock associated with burns. Tradition or evidence-based medicine? Resuscitation. 2000;44:157–64.

    Article  CAS  PubMed  Google Scholar 

  86. Boldt J, Papsdorf M. Fluid management in burn patients: results from a European survey: more questions than answers. Burns. 2008;34:328–38.

    Article  PubMed  Google Scholar 

  87. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317:235–40.

    Google Scholar 

  88. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.

    Article  CAS  PubMed  Google Scholar 

  89. Wilkes MM, Navickis RJ. Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2001;135:149–64.

    CAS  PubMed  Google Scholar 

  90. Alderson P, Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, Schierhout G, Albumin Reviewers. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004. doi:10.1002/14651858.CD001208.pub2.

  91. Coughlin MT, Angus DC. Economic evaluation of new therapies in critical illness. Crit Care Med. 2003;31:S7–16.

    Article  PubMed  Google Scholar 

  92. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med. 1999;341:403–9.

    Article  CAS  PubMed  Google Scholar 

  93. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–39.

    Article  CAS  PubMed  Google Scholar 

  94. Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med. 1989;87:359–60.

    Article  CAS  PubMed  Google Scholar 

  95. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest. 1983;71:726–35.

    Article  CAS  PubMed  Google Scholar 

  96. Legendre C, Thervet E, Page B, Percheron A, Noël LH, Kreis H. Hydroxyethyl starch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248–9.

    Article  CAS  PubMed  Google Scholar 

  97. Cittanova ML, Leblanc I, Legendre CH, Mouquet C, Riou B, Coriat P. Effect of hydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620–2.

    Article  CAS  PubMed  Google Scholar 

  98. Deman A, Peeters P, Sennesael J. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis. Nephrol Dial Transplant. 1999;14:1517–20.

    Article  CAS  PubMed  Google Scholar 

  99. Blasco V, Leone M, Antonini F, Geissler A, Albanèse J, Martin C. Comparison of the novel hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth. 2008;100:504–8.

    Article  CAS  PubMed  Google Scholar 

  100. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth. 2007;98:216–24.

    Article  CAS  PubMed  Google Scholar 

  101. Kumle B, Boldt J, Piper S, Schmidt C, Suttner S, Salopek S. The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg. 1999;89:1124–30.

    Article  CAS  PubMed  Google Scholar 

  102. Boldt J, Brenner T, Lehmann A, Lang J, Kumle B, Werling C. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of new starch preparation with gelatin. Intensive Care Med. 2003;29:763–9.

    PubMed  Google Scholar 

  103. Boldt J, Brosch C, Röhm K, Papsdorf M, Mengistu A. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. Br J Anaesth. 2008;100:457–64.

    Article  CAS  PubMed  Google Scholar 

  104. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatin during aortic aneurysm surgery. Br J Surg. 2007;94:427–33.

    Article  CAS  PubMed  Google Scholar 

  105. Godet G, Lehot JJ, Janvier G, Steib A, De Castro V, Coriat P. Safety of HES 130/0.4 (Voluven®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. Eur J Anaesthesiol. 2008;25:986–94.

    Article  CAS  PubMed  Google Scholar 

  106. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment. Anesth Analg. 2002;95:544–51.

    Article  CAS  PubMed  Google Scholar 

  107. Dehne M, Muhling J, Sablotzki A, Dehne K, Sucke N, Hempelmann G. Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment. J Clin Anesth. 2001;13:103–11.

    Article  CAS  PubMed  Google Scholar 

  108. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg. 2003;96:1453–9.

    Article  CAS  PubMed  Google Scholar 

  109. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost. 1997;78:974–83.

    CAS  PubMed  Google Scholar 

  110. Jonville-Bera AP, Autret-Leca E, Gruel Y. Acquired type I von Willebrand’s disease associated with highly substituted hydroxyethyl starch. N Engl J Med. 2001;345:622–3.

    Article  CAS  PubMed  Google Scholar 

  111. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat R. Voluven®, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg. 2001;92:855–62.

    Article  CAS  PubMed  Google Scholar 

  112. Joorgensen KA, Stoffersen E. Heparin-like activity of albumin. Thromb Res. 1979;16:69–74.

    Article  Google Scholar 

  113. Niemi T, Kuitunen A. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand. 2005;49:373–8.

    Article  CAS  PubMed  Google Scholar 

  114. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg. 2006;102:998–1006.

    Article  CAS  PubMed  Google Scholar 

  115. Tabuchi N, de Haan J, Gallandat Huet RC, Boonstra PW, van Oeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost. 1995;74:1447–51.

    CAS  PubMed  Google Scholar 

  116. de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost. 1998;79:286–90.

    PubMed  Google Scholar 

  117. Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg. 2002;95:858–65.

    Article  PubMed  Google Scholar 

  118. Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Br J Anaesth. 1997;78:44–50.

    CAS  PubMed  Google Scholar 

  119. Huttner I, Boldt J, Haisch G, Suttner S, Kumle B, Schulz H. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaesth. 2000;85:417–23.

    CAS  PubMed  Google Scholar 

  120. de Jonge E, Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med. 2001;29:1261–7.

    Article  PubMed  Google Scholar 

  121. Knutson JE, Deering JA, Hall FW, Nuttall GA, Schroeder DR, White RD, Mullany CJ. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg. 2000;90:801–7.

    Article  CAS  PubMed  Google Scholar 

  122. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg. 2001;72:527–33.

    Article  CAS  PubMed  Google Scholar 

  123. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend®) on measures of coagulation. Br J Anaesth. 2002;89:722–8.

    Article  CAS  PubMed  Google Scholar 

  124. Kozek-Langenecker SA, Jungheinrich C, Sauermann W. Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg. 2008;107:382–90.

    Article  CAS  PubMed  Google Scholar 

  125. Boldt J, Schölhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anesth Analg. 2006;103:191–9.

    Article  PubMed  Google Scholar 

  126. Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen PE, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F, Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238:641–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Hospital, Helsinki, Finland

    Tomi T. Niemi

  2. Department of Anesthesiology, Sapporo Medical University Hospital, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan

    Ryo Miyashita & Michiaki Yamakage

Authors
  1. Tomi T. Niemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ryo Miyashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michiaki Yamakage
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michiaki Yamakage.

About this article

Cite this article

Niemi, T.T., Miyashita, R. & Yamakage, M. Colloid solutions: a clinical update. J Anesth 24, 913–925 (2010). https://doi.org/10.1007/s00540-010-1034-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-010-1034-y

Keywords

Search

Navigation